| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | -0.03 | 0.5 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.5 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.6 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.032 | 0.6 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.6 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |